DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,241 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,477 | -93.2% | 933 | -93.4% | 0.03% | -92.9% |
| Q2 2023 | $3,389,760 | -73.4% | 14,124 | -72.1% | 0.46% | -73.6% |
| Q1 2023 | $12,767,338 | -8.1% | 50,656 | -3.2% | 1.75% | +3.7% |
| Q4 2022 | $13,885,182 | +17.8% | 52,314 | +14.6% | 1.69% | +16.2% |
| Q3 2022 | $11,790,000 | +0.8% | 45,648 | -1.1% | 1.45% | +5.5% |
| Q2 2022 | $11,700,000 | -9.7% | 46,151 | +4.5% | 1.38% | +11.8% |
| Q1 2022 | $12,958,000 | -22.9% | 44,175 | -13.5% | 1.23% | -14.2% |
| Q4 2021 | $16,810,000 | +7.9% | 51,094 | -0.2% | 1.44% | +0.4% |
| Q3 2021 | $15,582,000 | -0.6% | 51,183 | -12.4% | 1.43% | +1.1% |
| Q2 2021 | $15,672,000 | -7.4% | 58,400 | -22.3% | 1.42% | -8.7% |
| Q1 2021 | $16,928,000 | -1.1% | 75,208 | -2.4% | 1.55% | +0.5% |
| Q4 2020 | $17,115,000 | -0.8% | 77,044 | -3.8% | 1.54% | -6.5% |
| Q3 2020 | $17,250,000 | -4.2% | 80,111 | -21.3% | 1.65% | -18.5% |
| Q2 2020 | $18,000,000 | -2.4% | 101,795 | -23.6% | 2.02% | -21.7% |
| Q1 2020 | $18,437,000 | +318.4% | 133,206 | +363.9% | 2.58% | +406.7% |
| Q4 2019 | $4,407,000 | +14.0% | 28,715 | +7.2% | 0.51% | +5.6% |
| Q3 2019 | $3,867,000 | +6.9% | 26,775 | +5.8% | 0.48% | +7.6% |
| Q2 2019 | $3,618,000 | +7.2% | 25,312 | -0.9% | 0.45% | +1.1% |
| Q1 2019 | $3,374,000 | +28.5% | 25,554 | +0.4% | 0.44% | +9.1% |
| Q4 2018 | $2,626,000 | -6.4% | 25,461 | -1.4% | 0.41% | +3.8% |
| Q3 2018 | $2,807,000 | +10.2% | 25,835 | +0.1% | 0.39% | +3.2% |
| Q2 2018 | $2,547,000 | -78.1% | 25,809 | -78.3% | 0.38% | -78.7% |
| Q1 2018 | $11,630,000 | -7.1% | 118,786 | -11.9% | 1.78% | -3.7% |
| Q4 2017 | $12,521,000 | -10.9% | 134,898 | -17.7% | 1.85% | +2.8% |
| Q3 2017 | $14,058,000 | +0.1% | 163,883 | -1.5% | 1.80% | -3.6% |
| Q2 2017 | $14,046,000 | -1.9% | 166,443 | -0.6% | 1.87% | -5.2% |
| Q1 2017 | $14,321,000 | -14.2% | 167,438 | -21.9% | 1.97% | -7.6% |
| Q4 2016 | $16,697,000 | -42.0% | 214,507 | -41.5% | 2.13% | +12.7% |
| Q3 2016 | $28,764,000 | -1.9% | 366,938 | +26.4% | 1.89% | -5.3% |
| Q2 2016 | $29,328,000 | +6.0% | 290,380 | -0.4% | 2.00% | +4.9% |
| Q1 2016 | $27,658,000 | +110.6% | 291,574 | +106.2% | 1.90% | +6.7% |
| Q4 2015 | $13,133,000 | +13.1% | 141,396 | +3.8% | 1.78% | +9.6% |
| Q3 2015 | $11,612,000 | +10.1% | 136,280 | +10.6% | 1.63% | +9.6% |
| Q2 2015 | $10,550,000 | +0.7% | 123,263 | -0.1% | 1.48% | +4.6% |
| Q1 2015 | $10,477,000 | -6.4% | 123,408 | -5.5% | 1.42% | +6.8% |
| Q4 2014 | $11,188,000 | +2.7% | 130,533 | -9.0% | 1.33% | +16.3% |
| Q3 2014 | $10,895,000 | -21.6% | 143,390 | -18.8% | 1.14% | -16.3% |
| Q2 2014 | $13,902,000 | -0.8% | 176,581 | -5.5% | 1.37% | +3.9% |
| Q1 2014 | $14,017,000 | -1.9% | 186,896 | +1.0% | 1.32% | +6.5% |
| Q4 2013 | $14,289,000 | -5.3% | 185,086 | -15.0% | 1.24% | -4.5% |
| Q3 2013 | $15,096,000 | -26.6% | 217,779 | -33.0% | 1.29% | -16.8% |
| Q2 2013 | $20,565,000 | – | 324,879 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |